07:23 AM EDT, 03/26/2026 (MT Newswires) -- Kodiak Sciences ( KOD ) shares were 38% higher pre-bell Thursday after the company said that topline results from a phase 3 trial of tarcocimab tedromer demonstrated superiority over sham in patients with diabetic retinopathy and met its primary endpoint with high statistical significance.
Navan (NAVN) stock was up 24%, a day after the company reported it swung to fiscal Q4 earnings amid higher revenue.
Noodles (NDLS) shares were 19% higher after the company reported late Wednesday improved Q4 financial results.